HIV-1Transgenic Rat

 

Nomenclature: Hsd:HIV-1 (F344)

Information and Research Data
Click on Links Below
Health Monitoring Reports and Global Availability

 HIV-1 Transgenic Rat Origin

  • The HIV-1 rat was developed at the University of Maryland Biotechnology Institute (UMBI) from F344/NHsd stock.

HIV-1 Transgenic Rat Characteristics

  • Coat: Albino
  • Carries seven of the nine HIV genes
  • Noninfectious due to the functional deletion of Gag and Pol within the HIV-1 provirus
  • Develops immunologic dysfunction and AIDS-associated conditions by five to nine months of age
  • Develops moderate/severe skin lesions with age
  • Clinical signs of wasting syndrome
  • Early onset of cataracts
  • HIV-1 associated renal disease
  • Mild to moderate interstitial fibrosis
  • Control models: HIV-1 littermates lacking phenotypic characteristics, F344/NHsd rats
  • Sera contains gp120, which is in direct contrast to transgenic mice with the same proviral transgene
  • Viral genes are efficiently expressed in lymph nodes, spleen, thymus and blood, suggesting rat cyclin T is functional with Tat; mouse cyclin T is not functional with Tat and is only expressed in skin and muscle
  • Neurological abnormalities are similar to infected humans

HIV-1 Transgenic Rat Research Use

  • HIV-1 associated conditions
  • Immunology
  • Kidney disease
  • Cardiac disorders

Harlan Laboratories' Production

Clients are required to sign a Materials Transfer Agreement prior to acquiring animals for research use.

 

To contact a specialist, select your region